(Bloomberg) -- Fidji Simo is joining OpenAI in a new role as chief executive officer of applications, reporting to Sam Altman, he announced on Wednesday. Most Read from Bloomberg The Battle Over the Fate of Detroit’s Renaissance Center Vail to Borrow Muni Debt to Ease Ski Resort Town Housing Crunch Is Trump’s Plan to Reopen the Notorious Alcatraz Prison Realistic? Iceland Plans for a More Volcanic Future The 39-year-old executive will take over many of the AI startup’s operations, including finance, allowing Altman to focus on broader strategy. Simo will oversee several executives who previously reported to Altman, according to a person with knowledge of the matter. Her reports will include Chief Operating Officer Brad Lightcap, Chief Financial Officer Sarah Friar and Chief Product Officer Kevin Weil, said the person, who asked not to be identified discussing non-public management changes. The research, safety, and scaling organizations will continue to report to Altman, the person said. “In this new configuration I’ll be able to increase my focus on research, compute, and safety,” Altman said in a post on X. “These are critical as we approach superintelligence.” Simo will depart her role as CEO of Maplebear Inc., the operator of Instacart, in the coming months, she said in a separate statement. She’s led the grocery delivery company for four years, following a decade at Meta Platforms Inc. OpenAI this week scaled back a proposed plan to reconfigure into a for-profit entity. “In her new role, Fidji will focus on enabling our ‘traditional’ company functions to scale as we enter a next phase of growth,” Altman said in a statement posted to the OpenAI website. “We remain one OpenAI.” Simo joined OpenAI’s board in early 2024 as part of a slate of new directors installed after the brief ousting and return of Altman in late 2023. Raised in France, she has spent years in leadership roles in the tech industry; before Instacart, she served as vice president and head of the Facebook app at Meta. She also co-founded a medical clinic and research foundation called the Metrodora Institute, which is aimed at curing neuroimmune disorders. Instacart “expects that the company’s new CEO, who will be announced soon, will be one of its highly talented senior executives,” the company said in an emailed statement. --With assistance from Dina Bass. (Updates with additional details throughout) Most Read from Bloomberg Businessweek US Border Towns Are Being Ravaged by Canada’s Furious Boycott Pre-Tariff Car Buying Frenzy Leaves Americans With a Big Debt Problem Made-in-USA Wheelbarrows Promoted by Trump Are Now Made in China Inside the Dizzying Chaos of Running a Freight Business Under Trump Why Juggling IVF With Work Can Be a Career Killer ©2025 Bloomberg L.P. View Comments
OpenAI Recruits Instacart CEO Fidji Simo to Steer Operations
You are reading a free article with opinions that may differ from the recommendation given by Kalkine in its paid research reports. Become a Kalkine member today to get access to our research reports, in-depth technical and fundamental research. Learn more
Start Your Free Trial Now!Download Free Report – Explore 3 Stock Ideas & Industry Insights
Unlock 3 stock ideas and key industry insights in our free report. This information is general in nature and does not consider your personal objectives, financial situation, or needs. It is not financial advice.
All investments involve risk—consider independent advice before making any investment decisions.
View 3 Research ReportsThis information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on ‘as is’ basis, using their API. The information and data provided on this page, as well as via the API, are not guaranteed to be real-time or accurate. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general informational purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine does not assume any responsibility for any trading losses you might incur as a result of using this information, data, or any analyst rating or recommendation provided. Kalkine will not accept any liability for any loss or damage resulting from reliance on the information, including but not limited to data, quotes, charts, analyst ratings, recommendations, and buy/sell signals sourced via the API.
Please be fully informed about the risks and costs associated with trading in the financial markets, as it is one of the riskiest forms of investment. Kalkine does not provide any warranties regarding the information on this page, including, without limitation, warranties of merchantability or fitness for a particular purpose or use.
Please wait processing your request...